The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population
Learn more about:
Related Access Program
Related Clinical Trial
Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders
Identification of Autoantibodies and Autoantigens in the Cerebrospinal Fluid of Patients With Spinal Cord Trauma
Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure
Treo for BMFD Post HCT
The Evaluating Multidisciplinary Bone Marrow Failure Care in Bone Marrow Failure and Related Disorders.
TPO Use in Children for Hemotopoietic Failure
Trial of Haploidentical Stem Cell Transplantation for Haematological Cancers
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Unrelated Donor Transplant for Malignant and Non-Malignant Disorders
Pilot Trial of Clofarabine Added to Standard Busulfan and Fludarabine for Conditioning Prior to Allogeneic Hematopoietic Cell Transplantation
Memory T-cell Infusion to Improve Immunity After TCR-alpha/Beta Depleted Hematopoietic Stem Cell Transplantation
Expanded Access Protocol Using Alpha/Beta T and CD19+ Depleted PBSC
Reduced Intensity Conditioning Using CD3+/CD19+ Depletion for Non Malignant Transplantable Diseases
Eltrombopag for Enhancing Platelet Engraftment in Adult Patients Undergoing Cord Blood Transplantation
Umbilical Cord Blood Transplantation As Treatment Of Adult Patients With Hematologic Disorders
The Impact of Red Cell Age on Product Utilization in the Chronically Transfused Outpatient Population